AT
Arthur Tzianabos
DELAYED 1 MONTH
Director; Director, Interim Executive Chair
Stoke Therapeutics, Inc.
Filings
2
Companies
1
Latest
Jun 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
56
STOKCLUSTER 2
Stoke Therapeutics, Inc.
Arthur Tzianabos
Director, Interim Executive Chair
Sale
$174.2K
4,355 sh
Mar 12 8:57 PM
Mar 10, 2026
—
Stoke Therapeutics, Inc.
Arthur Tzianabos
Director, Interim Executive Chair
Option Exercise
$32.9K
3,955 sh
Mar 12 8:57 PM
Mar 10, 2026